Mark Willig

Rosetta Genomics has appointed Mark Willig as chief commercial officer. He will be responsible for sales, marketing, and market access for the company's entire diagnostic assay portfolio, and will be reporting to President and CEO Kenneth Berlin. Willig most recently served as senior vice president of sales for CardioDx. Before his time at CardioDx, he served as executive vice president of global sales for Agendia, and has also served in various positions at Thermo Fisher Scientific, PrognostiX, Abbott, and Myriad Genetics.